癌症疫苗市场基于(主要地区、市场参与者、规模和份额)- 预测至 2031 年

  • Report Code : TIPRE00004595
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Cancer Vaccines Market Share: 2021 to 2031 Key Findings

Buy Now

预计 2021 年癌症疫苗市场规模为 56.8 亿美元,2023 年将达到 xx 亿美元。预计到 2031 年将达到 168.6 亿美元,到 2031 年的复合年增长率为 11.5%。开发个性化癌症疫苗、专注于联合疗法以及增加对癌症疫苗研发活动的投资可能仍将是癌症疫苗市场的主要趋势。

 

癌症疫苗市场分析

全球癌症发病率的上升预计将推动癌症疫苗市场的增长。癌症是全球死亡的主要原因之一,对生活质量产生了深远影响。因此,如果不及时诊断和治疗,癌症将成为社会的负担。根据世界卫生组织的报告,2022 年癌症病例约为 19,976,499 例;预计到 2045 年癌症病例数将达到 3260 万例。

世界各地癌症发病率的不断上升,增加了全球对癌症疫苗的需求。

 

癌症疫苗市场概况

全球癌症疫苗市场按地区划分为北美、欧洲、亚太、中东和非洲以及南美和中美洲。该地区的市场增长预计是由于全球癌症患病率上升等因素,全球卫生研究组织和癌症疫苗主要参与者采取的举措。然而,预计在预测年内,用于治疗癌症的市售疫苗数量较少和疫苗成本高昂将在一定程度上阻碍市场增长。

 

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

癌症疫苗市场:

癌症疫苗市场
  • Cancer Vaccines Market
    复合年增长率(2023 - 2031)
    11.5%
  • 2021 年市场规模
    56.8 亿美元
  • 2031年市场规模
    168.6亿美元

市场动态

增长动力
  • 全球癌症发病率上升
未来的趋势
  • 发展中国家的新兴市场
机会
  • 不断增长的研发活动

关键人物;主力;重要一员

  • 港通有限公司
  • ADURO 生物技术有限公司
  • 安斯泰来制药公司
  • 默克公司
  • 赛诺菲
  • 百时美施贵宝公司
  • 葛兰素史克公司
  • 丹德里昂
  • 阿斯利康公司
  • OSE 免疫治疗公司

区域概况

Cancer Vaccines Market
  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

Cancer Vaccines Market技术
  • 树突状细胞癌症疫苗
  • 重组癌症疫苗
  • 抗原癌症疫苗
  • 全细胞癌症疫苗
  • 病毒载体癌症疫苗
Cancer Vaccines Market类型
  • 预防癌症疫苗
  • 治疗性癌症疫苗
Cancer Vaccines Market指征
  • 宫颈癌
  • 前列腺癌
  • 其他适应症
Cancer Vaccines Market最终用户
  • 儿科
  • 成年人
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

癌症疫苗市场驱动因素和机遇

全球卫生研究组织和主要参与者为癌症疫苗采取的举措有利于市场。

政府频繁推出举措和产品,推动疫苗市场发展。2024 年 2 月,印度政府启动了一项新计划,将 9-14 岁的女孩纳入 9-14 岁女孩 HPV 普遍免疫计划 (UIP)。这是确保疫苗更广泛普及和负担得起的重要一步。

 

新兴市场——癌症疫苗市场的机会

亚太地区的发展中国家正在为主要市场参与者创造更好的业务扩展机会。这些参与者中的大多数都专注于印度和中国等新兴市场,因为这些国家拥有大量癌症患者和日益增长的医疗旅游业。根据马来西亚医疗旅游委员会的数据,2022 年,超过 850,000 名医疗旅行者因各种医疗目的访问了马来西亚。手术成本低、手术技术先进、等待时间短,吸引了全球各地的人们前往这些发展中国家进行医疗程序,包括癌症筛查。癌症发病率的上升为市场创造了机会。例如,2022 年,印度记录了约 1,413,316 例新的癌症病例。因此,新兴国家不断升级的医疗旅游业和不断增长的癌症患病率为市场参与者提供了巨大的增长机会。

 

癌症疫苗市场报告细分分析

对癌症疫苗市场分析做出贡献的关键部分是服务和应用。

  • 根据技术,癌症疫苗市场细分为树突状细胞癌症疫苗、重组癌症疫苗、抗原癌症疫苗、全细胞癌症疫苗、病毒载体癌症疫苗。重组癌症疫苗部分在 2023 年占据了最大的市场份额,预计同一部分在预测期内将在市场上实现最高的复合年增长率。
  • 根据类型,癌症疫苗市场分为预防性癌症疫苗和治疗性癌症疫苗。预防性癌症疫苗部分在 2023 年占据了最大的市场份额,预计同一部分在预测期内将在市场上实现最高的复合年增长率。
  • 根据适应症,癌症疫苗市场分为宫颈癌、前列腺癌、其他适应症。宫颈癌领域在 2023 年占据了最大的市场份额,预计在预测期内,该领域将实现最高的复合年增长率。
  • 癌症疫苗市场已按最终用户细分为儿科和成人。儿科市场在 2023 年占据了最大的市场份额,预计在预测期内,该市场将实现最高的复合年增长率。

 

癌症疫苗市场份额(按地区)分析

癌症疫苗市场报告的地理范围主要分为五个地区:北美、亚太、欧洲、中东和非洲、南美/南美和中美。

北美包括美国、加拿大和墨西哥。2023 年,北美市场在全球市场中占有重要份额。该地区市场的需求预计将在预测期内以显着的速度增长,原因是多种因素,例如,对诊断和治疗癌症的需求不断增长、癌症发病率上升、高研发支出、市场参与者之间竞争加剧以及政府对研究机构开发新疗法的补助是推动市场增长的一些主要因素。

亚太地区是全球增长最快的癌症疫苗市场,这得益于日本和中国等国家癌症疫苗的不断发展。该地区癌症患者人数众多、研究数量不断增加、政府支持不断增加以及初创企业和生物技术公司数量不断增加,这些都是为市场增长创造增长机会的因素。

 

癌症疫苗市场报告范围

报告属性细节
2021 年市场规模56.8亿美元
2031 年市场规模168.6亿美元
全球复合年增长率(2023 - 2031)11.5%
历史数据2021-2022
预测期2024-2031
涵盖的领域按技术分类
  • 树突状细胞癌症疫苗
  • 重组癌症疫苗
  • 抗原癌症疫苗
  • 全细胞癌症疫苗
  • 病毒载体癌症疫苗
按类型
  • 预防癌症疫苗
  • 治疗性癌症疫苗
按适应症
  • 宫颈癌
  • 前列腺癌
  • 其他适应症
按最终用户
  • 儿科
  • 成年人
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • 港通有限公司
  • ADURO 生物技术有限公司
  • 安斯泰来制药公司
  • 默克公司
  • 赛诺菲
  • 百时美施贵宝公司
  • 葛兰素史克公司
  • 丹德里昂
  • 阿斯利康公司
  • OSE 免疫治疗公司
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

癌症疫苗市场新闻和最新发展

癌症疫苗市场通过收集一级和二级研究后的定性和定量数据进行评估,其中包括重要的公司出版物、协会数据和数据库。以下是癌症疫苗和策略市场发展情况的列表:

  • 2023 年 12 月,牛津大学医院针对头颈癌患者启动了新的 mRNA 癌症疫苗试验。(来源:公司新闻稿)
  • 2024 年 2 月,Moderna 的癌症疫苗 mRNA-4359 试验在帝国理工学院医疗保健 NHS 信托基金开始。该试验旨在评估该疗法在治疗黑色素瘤、肺癌和其他实体肿瘤癌症方面的安全性和潜在疗效
    (来源:公司新闻稿)

 

癌症疫苗市场报告覆盖范围和交付成果

“癌症疫苗市场规模和预测(2021-2031)”报告对以下领域进行了详细的市场分析:

  • 范围内所有主要细分市场的全球、区域和国家层面的市场规模和预测
  • 市场动态,如驱动因素、限制因素和关键机遇
  • 未来主要趋势
  • 详细的 PEST/波特五力分析和 SWOT 分析
  • 全球和区域市场分析涵盖关键市场趋势、主要参与者、法规和最新市场发展
  • 行业格局和竞争分析,涵盖市场集中度、热点图分析、知名参与者和最新发展
  • 详细的公司简介
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Life Sciences : READ MORE..